Jocelyn Silvester, MD PHD

NPI: 1295169480
Total Payments
$17,272
2024 Payments
$8,315
Companies
3
Transactions
8

Payment Breakdown by Category

Consulting$15,195 (88.0%)
Research$2,000 (11.6%)
Food & Beverage$76.94 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,195 5 88.0%
Unspecified $2,000 1 11.6%
Food and Beverage $76.94 2 0.4%

Payments by Type

General
$15,272
7 transactions
Research
$2,000
1 transactions

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $9,717 6 $0 (2024)
Teva Pharmaceuticals USA, Inc. $6,880 1 $0 (2021)
Chugai Pharmaceutical Co., Ltd. $675.00 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $8,315 4 Takeda Pharmaceuticals U.S.A., Inc. ($7,640)
2023 $29.10 1 Takeda Pharmaceuticals U.S.A., Inc. ($29.10)
2021 $8,880 2 Teva Pharmaceuticals USA, Inc. ($6,880)
2018 $47.84 1 Takeda Pharmaceuticals U.S.A., Inc. ($47.84)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/26/2024 Chugai Pharmaceutical Co., Ltd. Consulting Fee Cash or cash equivalent $675.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $3,320.00 General
06/27/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $3,320.00 General
03/19/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
05/07/2023 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $29.10 General
Category: INTERNAL MEDICINE
11/26/2021 Takeda Pharmaceuticals U.S.A., Inc. Cash or cash equivalent $2,000.00 Research
Study: ASSESSMENT OF IMMUNE ACTIVATION AND TOLERANCE IN CELIAC DISEASE DURING GLUTEN CHALLENGE
04/28/2021 Teva Pharmaceuticals USA, Inc. Consulting Fee Cash or cash equivalent $6,880.00 General
05/05/2018 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $47.84 General

Research Studies & Clinical Trials

Study Name Company Amount Records
ASSESSMENT OF IMMUNE ACTIVATION AND TOLERANCE IN CELIAC DISEASE DURING GLUTEN CHALLENGE Takeda Pharmaceuticals U.S.A., Inc. $2,000 1

About Jocelyn Silvester, MD PHD

Jocelyn Silvester, MD PHD is a Pediatric Gastroenterology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1295169480.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jocelyn Silvester, MD PHD has received a total of $17,272 in payments from pharmaceutical and medical device companies, with $8,315 received in 2024. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($15,195).

Practice Information

  • Specialty Pediatric Gastroenterology
  • Other Specialties Pediatrics
  • Location Boston, MA
  • Active Since 08/25/2013
  • Last Updated 06/13/2016
  • Taxonomy Code 2080P0206X
  • Entity Type Individual
  • NPI Number 1295169480

Products in Payments

  • ENTYVIO (Biological) $29.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Gastroenterology Doctors in Boston